Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190

C Routledge1, J Gurling, M A Ashworth-Preece

  • 1Department of Neuropharmacology, Wyeth Research, Maidenhead, Berkshire, UK.

European Journal of Pharmacology
|April 4, 1995
PubMed
Summary

Buspirone and NAN-190 are 5-HT1A receptor agonists that reduce serotonin release. Buspirone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-centric artificial intelligence and cancer research: construction of a real-world head and neck treatment data repository.

ESMO real world data and digital oncology·2026
Same author

Associations between inattention and impulsivity ADHD symptoms and disordered eating risk in a community sample of young adults.

Psychological medicine·2020
Same author

Interoception and disordered eating: A systematic review.

Neuroscience and biobehavioral reviews·2019
Same author

Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies.

Translational psychiatry·2016
Same author

Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2015
Same author

Effects of awareness that food intake is being measured by a universal eating monitor on the consumption of a pasta lunch and a cookie snack in healthy female volunteers.

Appetite·2015

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Serotonin (5-HT) plays a crucial role in regulating mood and behavior.
  • 5-HT1A receptors are key targets for anxiolytic and antidepressant drugs.
  • Buspirone and NAN-190 are known 5-HT1A receptor partial agonists influencing 5-HT release.

Purpose of the Study:

  • To investigate whether the decrease in 5-HT release induced by buspirone and NAN-190 is mediated through 5-HT1A receptor agonism.
  • To determine the specific role of somatodendritic 5-HT1A receptors in regulating 5-HT release.

Main Methods:

  • Administered buspirone and NAN-190 (selective 5-HT1A receptor agonists) to rats.
  • Measured extracellular 5-HT levels in hippocampal dialysates.
  • Utilized WAY-100135 (a selective 5-HT1A receptor antagonist) to block the effects of buspirone and NAN-190.

Related Experiment Videos

Main Results:

  • Both buspirone and NAN-190 significantly decreased extracellular 5-HT levels.
  • WAY-100135 successfully attenuated the inhibitory effect of buspirone on 5-HT release.
  • WAY-100135 did not significantly affect the reduction in 5-HT release caused by NAN-190.

Conclusions:

  • Buspirone's inhibitory effect on 5-HT release is mediated via agonism at somatodendritic 5-HT1A receptors.
  • NAN-190 may reduce 5-HT release through a mechanism distinct from, or in addition to, 5-HT1A receptor agonism.
  • These findings highlight differential mechanisms of action for 5-HT1A receptor agonists in regulating serotonin release.